Cargando…
Screening for Methylmalonic and Propionic Acidemia: Clinical Outcomes and Follow-Up Recommendations
Wisconsin’s newborn screening program implemented second-tier testing on specimens with elevated propionylcarnitine (C3) to aid in the identification of newborns with propionic and methylmalonic acidemias. The differential diagnosis for elevated C3 also includes acquired vitamin B12 deficiency, whic...
Autores principales: | Held, Patrice K., Singh, Emily, Scott Schwoerer, Jessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883915/ https://www.ncbi.nlm.nih.gov/pubmed/35225935 http://dx.doi.org/10.3390/ijns8010013 |
Ejemplares similares
-
Long-term outcomes in Amish patients diagnosed with propionic acidemia
por: Scott Schwoerer, Jessica, et al.
Publicado: (2018) -
Clinical Course and Nutritional Management of Propionic and Methylmalonic Acidemias
por: Mobarak, Amira, et al.
Publicado: (2020) -
Propionic and Methylmalonic Acidemias: Initial Clinical and Biochemical Presentation
por: Mobarak, Amira, et al.
Publicado: (2020) -
Biomarkers for drug development in propionic and methylmalonic acidemias
por: Longo, Nicola, et al.
Publicado: (2022) -
Neuropsychological endpoints for clinical trials in methylmalonic acidemia and propionic acidemia: A pilot study
por: Chapman, Kimberly A., et al.
Publicado: (2023)